NASDAQ:ARDS

Aridis Pharmaceuticals Stock Signals

etoro logo Buy ARDS
*Your capital is at risk
$0.0004
+0 (+0%)
At Close: Jul 10, 2026

Latest Data & Signals Issued

Below are some of the latest signals issued for Aridis Pharmaceuticals Inc.

General

Signal Type Signal Value Data
Score 0.000 94 days ( -100.00 %
Last Price $0.0004 0 %
Performance History
7 Days
$0.0004 $0.0004
0%
30 Days
$0.0002 $0.0004
100.00%
12 Mos
$0.0001 $0.0004
300.00%

8/18

Active Buy Signals

Specific Signals

Short Term
Net score: 50.68
Signal Type Signal Value Importance Data
High / Low N/A Very Low $0.0004 - $0.0004
Trend - 3 mos 13.20 % High Width: 841.72 %
Pred. range - 3 mos $0.0004 - $0.0038 Low -0.341 % - 838.51 %
Volume Direction Sell High Volume: 193 · Direction: 0
Pivot Short Buy Very Low Jun 26, 2026 - 10 days
RSI Short Pivot Signal Buy Very Low Jun 18, 2026 - 15 days
Short MA 3 mos Sell Low Jun 24, 2026 - 12 days
Long MA 3 mos Sell Medium Jun 24, 2026 - 12 days
Short/Long MA 3 mos Buy Medium Jun 29, 2026 - 9 days

Unlock Short Term Signals

Get access to powerful short-term trading signals and real-time market insights

Subscribe Now
Long Term
Net score: 42.91
Signal Type Signal Value Importance Data
Trend - 12 mos 31.74 % Very High Width: 2,657.07 %
Pred. range - 12 mos N/A - $0.0042 High -100.00 % - 946.94 %
Short MA 12 mos Sell Very High Jun 24, 2026 - 12 days
Long MA 12 mos Sell Very High Jun 24, 2026 - 12 days
Short/Long MA 12 mos Sell Very High Jul 01, 2026 - 7 days
Pivot Long Buy Low Jun 26, 2026 - 10 days
RSI Long Pivot Signal Buy Low Jul 06, 2026 - 5 days
Bollinger Sell Medium Nov 30, -0001 - N/A days
MACD Buy High No Dates Stored For This Signal
Click to get the best stock tips daily for free!
ABOUT ARIDIS PHARMACEUTICALS INC.
Aridis Pharmaceuticals
Aridis Pharmaceuticals, Inc., a late-stage biopharmaceutical company, focuses on the discovery and development of targeted immunotherapy using fully human monoclonal antibodies (mAb) to treat life-threatening infections. Its lead product candidate is AR-301, a fully human mAb of immunoglobulin 1 (IgG1) that is in Phase III pivotal trials for the treatment of lung infections resulting from S. aureus alphatoxin. The company is also developing AR-32...
GOLDEN STAR
Ticker Change Signal Date
SRPT
$17.02
11.34% Jun 29
NMRK
$15.02
1.20% Jun 24
NESR
$25.07
14.16% Jun 23
CAG
$13.43
2.98% Jun 23
GIB
$66.69
0.555% Jun 12

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE